ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,527 | +7.9% | 388 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $20,886 | +96.9% | 388 | +45.3% | 0.01% | +66.7% |
| Q1 2023 | $10,605 | -32.1% | 267 | -31.2% | 0.01% | -33.3% |
| Q4 2022 | $15,609 | +30.1% | 388 | 0.0% | 0.01% | +12.5% |
| Q3 2022 | $12,000 | 0.0% | 388 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $12,000 | -33.3% | 388 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $18,000 | +38.5% | 388 | 0.0% | 0.01% | +28.6% |
| Q3 2021 | $13,000 | -7.1% | 388 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $14,000 | 0.0% | 388 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $14,000 | +27.3% | 388 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $11,000 | -65.6% | 388 | -61.5% | 0.01% | -75.8% |
| Q2 2020 | $32,000 | -50.0% | 1,008 | -35.9% | 0.03% | -59.3% |
| Q1 2020 | $64,000 | -61.2% | 1,572 | -30.5% | 0.08% | -24.3% |
| Q3 2019 | $165,000 | -11.3% | 2,261 | 0.0% | 0.11% | -14.4% |
| Q2 2019 | $186,000 | +32.9% | 2,261 | +14.2% | 0.12% | +16.8% |
| Q1 2019 | $140,000 | -7.9% | 1,980 | -26.3% | 0.11% | +46.6% |
| Q3 2018 | $152,000 | – | 2,686 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |